NEW YORK (360Dx) – San Diego, California-based Biolinq said today that it has closed a $10 million Series A financing round.

The financing was led by Merck Ventures. Also participating was Hikma Ventures, as well as Grey Sky Venture Partners, Three Leaf Ventures, LifeSci Venture Partners, and a group of high-net-worth individuals who specialize in the field of diabetes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.